SCHEMBL30616751

SCHEMBL30616751

Cn1c(=O)cc(N2CCN(Cc3ccc(F)c(F)c3)CC2)c2nc(Cl)ccc21

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD4 P21917 3/20 0.42
GRM2 Q14416 3/20 0.42
ALDH1A1 P00352 1/20 0.41
HTT P42858 1/20 0.41
ABCC1 P33527 6/20 0.40
SIGMAR1 Q99720 2/20 0.39
TMEM97 Q5BJF2 1/20 0.39
KCNH2 Q12809 3/20 0.39
MCHR1 Q99705 1/20 0.39
CYP3A4 P08684 5/20 0.39
ABCB1 P08183 1/20 0.38
ABCG2 Q9UNQ0 1/20 0.38
PARP1 P09874 2/20 0.38
USP2 O75604 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
PPARG P37231 1/20 0.37
NCOA2 Q15596 1/20 0.37
NCOA1 Q15788 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30616757 0.93 SIGMAR1 (0.43) DRD4GRM2SIGMAR1KCNH2MCHR1
SCHEMBL30616711 0.88 GRM2 (0.41) DRD4GRM2ALDH1A1KCNH2PARP1
SCHEMBL29137184 0.88 DRD2 (0.40) DRD4ALDH1A1MAPT
SCHEMBL29137283 0.87 DRD4 (0.38) DRD4GRM2ALDH1A1SIGMAR1KCNH2
SCHEMBL30616722 0.85 GRM2 (0.44) DRD4GRM2ALDH1A1HTTKCNH2
SCHEMBL30616679 0.85 GRM2 (0.45) DRD4GRM2ALDH1A1HTTSIGMAR1
SCHEMBL29137205 0.84 ALDH1A1 (0.49) DRD4ALDH1A1HTTKCNH2CYP3A4
SCHEMBL30616712 0.83 GRM2 (0.44) DRD4GRM2ALDH1A1KCNH2PARP1
SCHEMBL29137279 0.83 DRD2 (0.43) DRD4ALDH1A1NPSR1HTR1AMAPT
SCHEMBL30616746 0.82 GRM2 (0.41) DRD4GRM2ALDH1A1HTTKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112585139-B Naphthyridinone compounds as T cell activators 百时美施贵宝公司 2023-12-01 CN disclosed